Cannon Kara 4
4 · ENZO BIOCHEM INC · Filed Nov 28, 2022
Insider Transaction Report
Form 4
Cannon Kara
DirectorChief Executive Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-11-23+200,000→ 200,000 totalExercise: $1.97From: 2023-11-23Exp: 2027-11-23→ Common Stock (200,000 underlying)
Holdings
- 52,000
Stock Option (to acquire Common Stock)
Exercise: $2.80From: 2020-01-03Exp: 2024-01-03→ Common Stock (52,000 underlying) - 87,500
Stock Option (to acquire Common Stock)
Exercise: $2.98From: 2023-03-24Exp: 2027-03-24→ Common Stock (87,500 underlying) - 87,500
Stock Option (to acquire Common Stock)
Exercise: $3.36From: 2023-02-11Exp: 2027-02-11→ Common Stock (87,500 underlying) - 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying) - 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (55,400 underlying) - 35,000
Stock Option (to acquire Common Stock)
Exercise: $4.42From: 2019-07-31Exp: 2023-07-30→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 200,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
- [F2]The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.